In this issue of Blood, Greiner and colleagues describe how peptides derived from the mutated nucleophosmin 1 gene (NPM1mut) can elicit in vitro CD4+ and CD8+ T-cell responses in patients with acute myeloid leukemia, which can lead to antigen-specific lysis of leukemic blasts. (Chemical Equation Presented).
CITATION STYLE
Berneman, Z. N. (2012, August 9). Autologous T cells on the attack against AML. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2012-06-433177
Mendeley helps you to discover research relevant for your work.